Sign in
Industry
Pharma
Biopharma
Vaccine
Biomed
Regulatory
Technology
Leader Spotlight
Academia
Science & Society
Research Spotlight
Scientist Spotlight
PhD & Postdoc
Awards
Campus Konnect
Fellowship & Grants
Conference & Training
Startup
Healthcare
Startup Konnect
Incubation Center
Startup Grants
Interviews
SciFocus TV
Sci Career Konnect
PhD Konnect
Storify India
Mentor Konnect
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Biopatrika
To bring science to society
Biopatrika
To bring science to society
Go
Search
Industry
Startup
Academia
Interviews
Category:
Startup Konnect
Academia
Awards
Biomed
Biopharma
Campus Konnect
Conference & Training
Science & Society
Global Trends in Antibiotic Consumption: 2016–2023 and Projections Through 2030
Press Release
Accord BioPharma Announces Agreement by Intas Pharmaceuticals, Ltd. to Acquire UDENYCA® (pegfilgrastim-cbqv) Business from Coherus BioSciences, Inc., Unlocking Potential for Continued U.S. Growth
Science & Society
A Blueprint for Broadly Effective Phage-Antibiotic Cocktails
Startup Konnect
Journey of sailing through aspirations and research leading to entrepreneurship
Startup Konnect
Listen to your gut: A step towards a personalized nutrition
Startup Konnect
Celebrating Women’s day with D-Fibroheal Scarlite
Startup Konnect
The Healing Nanos
Startup Konnect
Stop complaining and find a solution with Dr. Shambhavi Naik and Pushkar Potdar
Startup Konnect
A story of a science communicator-cum-entrepreneur
Startup Konnect
Fibroheal launches post operative wound care and wound closure dressings range for infected and non infected wounds using silk
Startup Konnect
You have to believe it, before you see it
Startup Konnect
An Inquisitive Entrepreneur on a Mission to Build a Disease Free World
Load more
Global Trends in Antibiotic Consumption: 2016–2023 and Projections Through 2030
December 5, 2024
Accord BioPharma Announces Agreement by Intas Pharmaceuticals, Ltd. to Acquire UDENYCA® (pegfilgrastim-cbqv) Business from Coherus BioSciences, Inc., Unlocking Potential for Continued U.S. Growth
December 4, 2024
A Blueprint for Broadly Effective Phage-Antibiotic Cocktails
December 3, 2024
U.S. FDA Approves Biocon Biologics’ YESINTEK™, Bmab 1200 biosimilar
December 1, 2024
Persistence of Spike Protein in Brain Borders May Drive COVID-19 Neurological Symptoms
December 1, 2024